86
0
0
Like?
Please wait...
About This Project
BioPeers – Peers Center for Biotech and Society
Our bodies produce very low doses of N,N-Dimethyltryptamine (DMT), a psychotropic substance. Recent findings suggest that DMT is an important modulator of Sig-1R, a receptor that plays important roles in neuropsychiatric diseases like schizophrenia, and depression. This project aims to further develop a hypothesis for the relation between DMT and Sig-1R, in hopes of providing novel insight into these neuropsychiatric diseases.

Browse Other Projects on Experiment
Related Projects
Are climate change and air pollution triggering cardiovascular disease?
Ongoing global climate change and air pollution emissions pose a major threat to cardiovascular health...
Developing a new tissue preservation method inspired by Tardigrades
There are two routine ways to preserve tissues: formalin-fixed paraffin-embedded preservation (FFPE) and...
How does taking Ritalin affect depersonalization-derealization disorder patients?
We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...